Paper Details

  1. Home
  2. Paper Details

Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.

Author: AuroraS K, BahraA, FerrariM D, GoadsbyP J, MartinV, MathewN T, RamadanN, van VlietJ A

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Current evidence-based treatments for cluster headache include oxygen inhalation and subcutaneous sumatriptan. Intranasal sumatriptan is a new formulation with better tolerability than the subcutaneous route. Two open-label studies suggested efficacy of intranasal sumatriptan in cluster headache.
Paper Details　
Original Abstract of the Article :
Current evidence-based acute treatments of cluster headache are limited to oxygen inhalation and subcutaneous sumatriptan. Intranasal sumatriptan is a new formulation with better tolerability than the subcutaneous route. Two open-label studies suggested efficacy of intranasal sumatriptan in cluster ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1212/01.wnl.0000046589.45855.30

データ提供：米国国立医学図書館（NLM）

Fighting Cluster Headaches: Intranasal Sumatriptan as a New Weapon

Cluster headaches are a debilitating condition that can leave individuals feeling helpless and overwhelmed. This study examines the effectiveness of intranasal sumatriptan, a new formulation of the drug, in treating acute cluster headaches. The researchers conducted a randomized placebo-controlled double-blind study to compare the efficacy of intranasal sumatriptan to a placebo. Their findings suggest that intranasal sumatriptan is a promising treatment option for acute cluster headaches.

Intranasal Sumatriptan: A Potential Solution for Cluster Headache Relief

This study provides evidence for the effectiveness of intranasal sumatriptan in alleviating acute cluster headaches. The results suggest that this new formulation might be a valuable addition to the therapeutic arsenal for treating this debilitating condition. This is particularly relevant considering the limited options currently available for acute cluster headache treatment and the potential for improved quality of life for patients suffering from these headaches.

Navigating Cluster Headaches: Finding Relief with Intranasal Sumatriptan

Picture a camel navigating a treacherous desert landscape, seeking refuge from the scorching sun. Cluster headaches can feel like a relentless heatwave, leaving individuals feeling exhausted and disoriented. This study suggests that intranasal sumatriptan could be a welcome oasis, offering relief from the intense pain and allowing individuals to regain control over their lives. It's essential to consult with your healthcare provider to explore whether intranasal sumatriptan is the right treatment for you and to discuss potential benefits and risks.

Dr.Camel's Conclusion

This study highlights the ongoing quest for effective treatments for cluster headaches. Intranasal sumatriptan offers a new avenue for relief, providing hope for a more manageable journey through the desert of pain. Remember, just as a camel adapts to its surroundings, so too can we learn to manage our health challenges with new knowledge and innovative treatments.

Date :
  1. Date Completed 2004-01-29
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

12601104

DOI: Digital Object Identifier

10.1212/01.wnl.0000046589.45855.30

Related Literature

Article Analysis
・Effects of sumatriptan nasal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.